$2.80
0.051.82%
At close: -
$2.85
0.051.79%
After Hours: Nov 20, 4:02 PM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for Relmada Therapeutics in recent months.
Browse guidance and forecast on all stocks.